INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2023, Number 4

Cardiovasc Metab Sci 2023; 34 (4)

The usefulness of the EuroSCORE II model for predicting surgery mortality in a high specialty hospital in Mexico

Teniente-Valente, Raúl; Martínez-Bautista, Humberto; Chagolla-Santillán, Miguel Ángel; Acevedo-Bañuelos,Iliana; Romo-Escamilla, Ricardo; García-Muñoz, Iván; Gutierrez-García, Mercedes Guadalupe; Rodríguez-Jiménez, José Carlos; Valente-Acosta, Benjamín; Vázquez-Martínez, Víctor Hugo

ABSTRACT

Introduction: the EuroSCORE model has been used in various countries, including México, to estimate the probability of surgery-associated mortality. Several studies have shown deficiencies in its calibration while retaining good discrimination. The model was updated in 2012 and called EuroSCORE II. Objective: to evaluate the calibration and discrimination of the EuroSCORE II model in patients undergoing cardiac surgery in a high specialty hospital in México. Material and methods: an observational, cross-sectional, and retrospective study was performed. Patients ≥ 16 years old years who underwent cardiac surgery between the years 2008-2013 were included. The hospital mortality rate was obtained, and the EuroSCORE II was calculated online. Discrimination of the EuroSCORE II model was evaluated with the area under the curve of a receiver operating characteristics curve (AUC-ROC), and the calibration was assessed using χ2 of Hosmer-Lemeshow (H-L) goodness of fit test and risk-adjusted ratio (RAMR). Results: three hundred thirty-eight patients were included. The mean age of participants was 49.8 ± 16.61 years; 162 were women (47.9%), and 176 (52.1%) were men. Surgery types were valvular 108 (31.9%), coronary revascularization 101 (29.8%), congenital 51 (15.08%), and other 78 (23.07%). The average EuroSCORE II was 4.1 (95% CI, 3.53-4.68). Mortality observed was 10.9%. The AUC-ROC was 0.806 (95% CI, 0.739-0.872), consistent with good discrimination. The χ2 of H-L of 14.2, p = 0.08, compatible with adequate calibration. The RAMR was 2.65, indicating an underestimation of the model. Conclusion: the EuroSCORE II model showed good discrimination. The calibration was adequate according to the χ2 of H-L, but the value of the RAMR suggests that the model underestimates the risk of mortality.
  FULL TEXT PDF  

Keywords

EuroSCORE II cardiac surgery heart surgery risk calculator validation




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Observational Registry for Cardiac Ablation in Atrial Fibrillation in Mexico...
    2025, Vol.36, Núm. 1
  • Leptin: a description of its intriguing biology. A review. Part I
    2025, Vol.36, Núm. 1
  • Metformin in the management of non-alcoholic fatty liver disease: current...
    2025, Vol.36, Núm. 1
  • Prophylactic use of intravascular balloon occlusion in elective general...
    2025, Vol.36, Núm. 1
  • Inflammation indices in chronic stable coronary artery disease
    2025, Vol.36, Núm. 1
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3

Cardiovascular and Metabolic Science Vol. 34, Num. 4, Octubre-Diciembre 2023. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail addresses: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: 2683-2828 versión impresa y 2954-3835 versión electrónica. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 04 de abril de 2024.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/